HomeIMVT • NASDAQ
add
Immunovant Inc
Previous close
$15.75
Day range
$15.50 - $16.45
Year range
$12.72 - $34.47
Market cap
2.80B USD
Avg Volume
1.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 113.82M | 40.73% |
Net income | -106.45M | -41.33% |
Net profit margin | — | — |
Earnings per share | -0.64 | -23.08% |
EBITDA | -113.72M | -40.71% |
Effective tax rate | -0.55% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 713.97M | 12.37% |
Total assets | 776.22M | 16.49% |
Total liabilities | 68.78M | 41.49% |
Total equity | 707.45M | — |
Shares outstanding | 170.92M | — |
Price to book | 3.79 | — |
Return on assets | -47.54% | — |
Return on capital | -53.68% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -106.45M | -41.33% |
Cash from operations | -110.64M | -85.32% |
Cash from investing | -201.00K | -34.00% |
Cash from financing | 450.61M | 29,065.83% |
Net change in cash | 339.29M | 710.53% |
Free cash flow | -75.00M | -115.21% |
About
Founded
2018
Website
Employees
362
